Literature DB >> 22674396

Levels of neuroglobin in serum and neurocognitive impairments in Chinese patients with obstructive sleep apnea.

Min Xu1, Ying Yang, Junjian Zhang.   

Abstract

PURPOSE: The impact of different severities of obstructive sleep apnea (OSA) on cognition has not well been documented. Neuroglobin, a recently discovered vertebrate protein, shows a neuroprotective function to modulate hypoxic-ischemic brain injury. This study investigated the cognitive function of patients with varying OSA severities and intended to explore the relationship between levels of neuroglobin in serum and cognitive deficits of OSA.
METHODS: Sixty Chinese adults aged 18-59 years old were enrolled and categorized into four groups based on apnea-hypopnea index (AHI): primary snoring (n = 7), mild (n = 13), moderate (n = 20), and severe (n = 20) OSA groups. Computer-based neurocognitive tests (including calculation, memory, and attention) and Epworth sleepiness scale were administered before polysomnographic monitoring, and blood sample was taken the next morning. Concentrations of serum neuroglobin were measured using ELISA.
RESULTS: No significant difference was observed in cognitive function regardless of OSA severities, but patients with moderate and severe OSA presented significantly more sleepiness than patients with primary snoring and mild OSA. Memory significantly correlated with time spent with oxygen saturation below 90 % during nighttime (T < 90 %), as well as oxygen desaturation index, AHI, or NREM sleep. Calculation correlated significantly with sleepiness and respiratory arousal index. Levels of neuroglobin in serum of patients with varying OSA severities were significant elevated than that of patients with primary snoring. No relationship was found between the neurobehavioral ability index of neurocognitive tests and serum neuroglobin concentrations after controlling for gender, age, and BMI, whereas the unique association between levels of neuroglobin in serum and the scores of auditory digit span test was noted.
CONCLUSIONS: Our findings suggest that different neurocognitive domains might specifically correlate to either sleepiness or hypoxemia. Changes of concentrations of neuroglobin in serum may possibly be used as an indicator to monitor the brain damage of OSA. Further investigations are needed to explore the relationship between regulation of neuroglobin in serum and severity of brain damage in OSA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22674396     DOI: 10.1007/s11325-012-0723-1

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  42 in total

1.  Utility of the WHO neurobehavioral core test battery in Chinese workers-a meta-analysis.

Authors:  Wei Zhou; Youxin Liang; David C Christiani
Journal:  Environ Res       Date:  2002-02       Impact factor: 6.498

2.  Validation of a Chinese version of the Epworth sleepiness scale.

Authors:  Ning-Hung Chen; Murray W Johns; Hseuh-Yu Li; Chia-Chen Chu; Shu-Cheng Liang; Yu-Hsiang Shu; Ming-Lung Chuang; Pa-Chun Wang
Journal:  Qual Life Res       Date:  2002-12       Impact factor: 4.147

Review 3.  Effect of sleep apnea on cognition and mood.

Authors:  Baruch El-Ad; Peretz Lavie
Journal:  Int Rev Psychiatry       Date:  2005-08

Review 4.  Cognitive deficits associated with sleep apnea syndrome: a proposed neuropsychological test battery.

Authors:  A Décary; I Rouleau; J Montplaisir
Journal:  Sleep       Date:  2000-05-01       Impact factor: 5.849

5.  Hypoxemia correlates with attentional dysfunction in patients with obstructive sleep apnea.

Authors:  Isaac Shpirer; Arnon Elizur; Ran Shorer; Ruth Bernstein Peretz; Jose M Rabey; Michael Khaigrekht
Journal:  Sleep Breath       Date:  2011-09-04       Impact factor: 2.816

Review 6.  Neuropsychological sequelae of obstructive sleep apnea-hypopnea syndrome: a critical review.

Authors:  Mark S Aloia; J Todd Arnedt; Jennifer D Davis; Raine L Riggs; Desiree Byrd
Journal:  J Int Neuropsychol Soc       Date:  2004-09       Impact factor: 2.892

7.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

8.  Cytoglobin expression is upregulated in all tissues upon hypoxia: an in vitro and in vivo study by quantitative real-time PCR.

Authors:  E Fordel; E Geuens; S Dewilde; P Rottiers; P Carmeliet; J Grooten; L Moens
Journal:  Biochem Biophys Res Commun       Date:  2004-06-25       Impact factor: 3.575

9.  Regulation of hypoxic neuronal death signaling by neuroglobin.

Authors:  Adil A Khan; Xiao Ou Mao; Surita Banwait; Celine M DerMardirossian; Gary M Bokoch; Kunlin Jin; David A Greenberg
Journal:  FASEB J       Date:  2008-01-15       Impact factor: 5.191

10.  What is the function of neuroglobin?

Authors:  Thorsten Burmester; Thomas Hankeln
Journal:  J Exp Biol       Date:  2009-05       Impact factor: 3.312

View more
  4 in total

1.  Combined effect of obstructive sleep apnea and chronic smoking on cognitive impairment.

Authors:  Ying Ni Lin; Li Na Zhou; Xiu Juan Zhang; Qing Yun Li; Qiong Wang; Hua Jun Xu
Journal:  Sleep Breath       Date:  2015-04-24       Impact factor: 2.816

2.  Optic disc and retinal nerve fiber layer parameters as indicators of neurodegenerative brain changes in patients with obstructive sleep apnea syndrome.

Authors:  Nergiz Huseyinoglu; Metin Ekinci; Serkan Ozben; Cagatay Buyukuysal; Murat Yildirim Kale; Hilal Safak Sanivar
Journal:  Sleep Breath       Date:  2013-05-01       Impact factor: 2.816

3.  Abnormal resting-state functional connectivity within the default mode network subregions in male patients with obstructive sleep apnea.

Authors:  Hai-Jun Li; Xiao Nie; Hong-Han Gong; Wei Zhang; Si Nie; De-Chang Peng
Journal:  Neuropsychiatr Dis Treat       Date:  2016-01-19       Impact factor: 2.570

4.  Periodic limb movements in patients with obstructive sleep apnea syndrome.

Authors:  Xiaobo Zhou; Bo Zhou; Zhe Li; Qiao Lu; Shaoping Li; Zhongyin Pu; Fang Luo
Journal:  Sci Rep       Date:  2021-07-28       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.